A Call to Arms…Legs, Brains, and Kidneys!  by White, Christopher J.
EA
E
I
i
N
n
l
l
i
d
a
h
t
a
r
g
o
h
t
S
c
v
A
p
a
w
e
f
v
t
b
t
f
p
t
T
a
b
b
J A C C : C A R D I O V A S C U L A R I N T E R V E N T I O N S V O L . 2 , N O . 5 , 2 0 0 9
© 2 0 0 9 B Y T H E A M E R I C A N C O L L E G E O F C A R D I O L O G Y F O U N D A T I O N I S S N 1 9 3 6 - 8 7 9 8 / 0 9 / $ 3 6 . 0 0
P U B L I S H E D B Y E L S E V I E R I N C . D O I : 1 0 . 1 0 1 6 / j . j c i n . 2 0 0 9 . 0 3 . 0 0 1
Christopher J. White,
MD
Associate Editor,
JACC: Cardiovascular
Interventions
. . . atherosclerotic
vascular disease is not
limited to the heart
and coronary arteries,
and atherosclerosis
does not fit neatly
into the “departmen-
tal silos” of academia.
Besides the heart,
atherosclerosis com-
monly affects several
clinically important
vascular territories
including the brain,
the viscera, the kid-
neys, and the limbs.DITOR’S PAGE
Call to Arms. . .Legs, Brains, and Kidneys!
ditor’s Note: In order to strengthen the Journal’s commitment to vascular disease outside the heart,
am pleased to announce that Chris White has joined the journal as an associate editor. The follow-
ng reflects his clinical wisdom and editorial expertise.
—Spencer B. King III, MD
o interventional cardiologist would argue with the primacy of “atherosclerosis” as the domi-
ant cardiovascular disease threatening our patients. Interventional cardiologists have estab-
ished a reputation of providing expert, evidence-based patient care; recommending appropriate
ife-style modification, antilipid therapy, and antithrombotic therapy; and the remarkable abil-
ty, on a national scale, to mobilize around-the-clock on-demand treatment for acute myocar-
ial infarctions. So what is wrong with this picture?
The fact is, atherosclerotic vascular disease is not limited to the heart and coronary arteries,
nd atherosclerosis does not fit neatly into the “departmental silos” of academia. Besides the
eart, atherosclerosis commonly affects several clinically important vascular territories including
he brain, the viscera, the kidneys, and the limbs. Why would well-meaning, highly-trained,
nd very talented interventional cardiologists fail to embrace the opportunity and accept the
esponsibility to treat cardiovascular disease in all of its manifestations? In the past, cardiolo-
ists have been guilty of tunnel-vision, of narrowly focusing their attention on the heart, while
ther vascular beds were left to the care of a variety of subspecialists. In addition, in many
ospitals, “turf wars” have resulted in barriers preventing cardiologists from treating vascular
erritories beyond the heart.
In an effort to broaden cardiovascular fellowship training, the Core Cardiology Training
ymposium (COCATS) document was revised in 2002 to include Task Force 11, which spe-
ifically prescribes training in vascular medicine and peripheral vascular catheter-based inter-
entions (1). To facilitate engagement of post-graduate (practicing) cardiologists, in 2004 the
merican College of Cardiology (ACC) organized a consensus document, endorsed by multi-
le vascular-related specialties, to outline a pathway to clinical competence in vascular medicine
nd peripheral vascular interventions (2). Finally, the American Board of Vascular Medicine
as formed with sponsorship from the ACC, the Society of Vascular Medicine, and the Soci-
ty of Cardiovascular Angiography and Interventions and held its first certifying examination
or cardiovascular specialists in both vascular medicine and endovascular medicine in 2005 (3).
That there is a great unmet need for catheter-based treatment of patients with noncoronary
ascular disease is not in doubt. From cerebrovascular disease to limb salvage there are pa-
ients, very often “our” patients, that are in need of a cardiovascular specialist who can provide
oth medical and interventional care. One of the largest discrepancies in health care delivery is
he difference between the care given to a patient with a heart attack and his twin brother suf-
ering a stroke, both brought to a hospital at 2:00 AM.
The heart attack patient is immediately triaged to acute care and has an electrocardiogram
erformed within 5 min revealing ST-segment elevation, which results in immediate mobiliza-
ion of the catheterization laboratory team to achieve a “door to balloon time” of 90 min.
his is a national quality standard uniformly endorsed by professional societies and accrediting
gencies.
The brother with the stroke arrives at the same hospital. Because he had been asleep for 4 h
efore he awoke with his stroke, he is beyond the 3-h time limit to receive intravenous throm-
olysis, and because he lives in 1 of the 5 states that do not have a neuroradiologist, there is
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477ot a physician who can provide invasive reperfusion ther-
py for his stroke. He is managed, and I use that term
oosely, without any attempt at revascularization. Unfortu-
ately, there is no national quality standard for acute
troke reperfusion therapy, and there is little hope for im-
rovement on the horizon.
The lack of interventional reperfusion options for acute
troke is a national embarrassment. Everyone seems to be
n-board with early reperfusion therapy for acute heart
ttacks, while stroke, the largest single cause of adult dis-
bility, languishes in the “can’t do” category. Despite
uidelines for comprehensive stroke centers, few are func-
ional because there are not enough physicians to provide
4/7 on-demand physician coverage. It is estimated that
ewer than 2% of all stroke patients in this country actu-
lly receive intravenous thrombolysis, while a total of 385
nterventional neuroradiologists practicing in 238 hospitals
overing 45 states are available to provide national,
round-the-clock stroke coverage (4). This is the “ele-
hant in the room” when quality metrics such as door-to-
reatment time for stroke therapy are discussed. Everyone
nows additional manpower is needed to provide on-de-
and reperfusion therapy for stroke, but turf battles make
t difficult for interventional cardiologists, particularly
hose with carotid stent skills, to lend a hand.
Likewise, hypertension and renal failure are both major
ontributors to morbidity and mortality in cardiovascular
atients. Renal artery stenosis, a cause of both, is more
revalent (15% to 20%) in our cardiovascular atheroscle-
otic population than previously thought. We can move
his field forward by disseminating knowledge of the ap-
ropriate screening strategies and by practicing evidence-
ased medicine when selecting patients for catheter-based
reatment. Both are keys to a successful renovascular
trategy for interventional cardiologists.
Finally, lower limb ischemia (typical and atypical clau-
ication), which limits physical activity, restricts mobility,
nd compromises fitness, is present in a sizeable number
f our coronary artery disease patients. Physical activity, a
ell-accepted surrogate for survival, means that physicians
ave a strong incentive to enable their patients to walk
nd to be physically active. Catheter-based revasculariza-
ion, in addition to pharmacologic and exercise therapies,re critical elements in any effective lower limb ischemia
reatment strategy.
Why should an interventional cardiologist participate in
total body” catheter-based vascular care? First, it is well
ecognized that atherosclerosis is a systemic disease, not
imited to the coronary circulation. If our patients have
oronary disease, inevitably there are other vascular terri-
ories that are affected. Second, interventional cardiolo-
ists are arguably the most skilled providers of catheter-
ased therapies, the dominant therapies for atherosclerotic
ascular diseases. Third, interventional cardiologists pro-
ide a continuum of care from the outpatient clinic to the
nterventional suite, including long-term follow up, per-
aps the single most important element when caring for
atients with a chronic disease.
In an effort to assist and support interventional cardiol-
gists’ efforts to improve their fund of knowledge relevant
o noncoronary vascular diseases, JACC: Cardiovascular
nterventions offers a forum to exchange ideas, to intro-
uce novel clinical approaches and device-based strategies,
nd above all, to improve patient outcomes.
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